These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26805208)

  • 21. [Complete response in a case of advanced esophageal cancer infiltrating into the main bronchus treated by chemoradiation therapy].
    Tsukao Y; Yamazaki M; Miyazaki Y; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2124-6. PubMed ID: 24394034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of docetaxel, cisplatin, and 5-fluorouracil chemotherapy for superficial esophageal squamous cell carcinoma.
    Miyawaki Y; Nakajima Y; Kawada K; Okada T; Tokairin Y; Kawano T
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27001629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I/II study of divided-dose docetaxel, cisplatin and fluorouracil for patients with recurrent or metastatic squamous cell carcinoma of the esophagus.
    Ojima T; Nakamori M; Nakamura M; Katsuda M; Hayata K; Matsumura S; Iwahashi M; Yamaue H
    Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 26725778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
    J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis.
    Kushida T; Nohara S; Yoshino K; Fujiwara D; Ouchi K; Amano T; Isayama F; Tomita N; Iwanuma Y; Sasai K; Tsurumaru M; Kajiyama Y
    Dis Esophagus; 2014; 27(4):368-73. PubMed ID: 23865505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer.
    Shiozaki A; Yamagishi H; Itoi H; Fujiwara H; Kikuchi S; Okamoto K; Ichikawa D; Fuji N; Ochiai T; Sonoyama T; Ueda Y
    Oncol Rep; 2005 Apr; 13(4):667-72. PubMed ID: 15756440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A Case of Granulocyte-Colony Stimulating Factor Producing Esophageal Carcinoma].
    Tochimoto M; Watanabe T; Koyama K; Sadamura K; Iwaki Y; Katoh H; Kawaguchi M; Tawaraya K; Hosokawa O; Yanagimoto K
    Gan To Kagaku Ryoho; 2018 Sep; 45(9):1353-1355. PubMed ID: 30237380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant Chemotherapy with Divided-dose Docetaxel, Cisplatin and Fluorouracil for Patients with Squamous Cell Carcinoma of the Esophagus.
    Ojima T; Nakamori M; Nakamura M; Katsuda M; Hayata K; Kato T; Kitadani J; Tabata H; Takeuchi A; Iwahashi M; Yamaue H
    Anticancer Res; 2016 Feb; 36(2):829-34. PubMed ID: 26851048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose escalation study of docetaxel and nedaplatin in patients with relapsed or refractory squamous cell carcinoma of the esophagus pretreated using cisplatin, 5-fluorouracil, and radiation.
    Yoshioka T; Sakayori M; Kato S; Chiba N; Miyazaki S; Nemoto K; Shibata H; Shimodaira H; Ohtsuka K; Kakudo Y; Sakata Y; Ishioka C
    Int J Clin Oncol; 2006 Dec; 11(6):454-60. PubMed ID: 17180514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of esophageal squamous cell carcinoma with an adenocarcinoma component that dedifferentiated after chemotherapy].
    Nemoto H; Tate G; Umemoto T; Matsubara T; Mizukami H; Saito M; Kigawa G; Matsumiya A; Tanaka J
    Gan To Kagaku Ryoho; 2014 Jul; 41(7):909-12. PubMed ID: 25131883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-Term Complete Response in Postoperative Multiple Lung and Mediastinal Lymph Node Metastases of Esophageal Cancer Using Systemic Chemotherapy with DCF Treatment - A Case Report].
    Katsumi C; Bamba T; Nakagawa S; Aizawa M; Matsuki A; Yabusaki H; Homma K
    Gan To Kagaku Ryoho; 2017 Jan; 44(1):75-78. PubMed ID: 28174385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathologic complete response of thoracic esophageal cancer developing after gastrectomy to neoadjuvant low-dose nedaplatin (CDGP), 5-fluorouracil and radiotherapy].
    Takemura M; Osugi H; Lee S; Nishikawa T; Fukuhara K; Iwasaki H
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):1023-7. PubMed ID: 16044966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
    Izumi D; Yoshida N; Watanabe M; Shiraishi S; Ishimoto T; Kosumi K; Tokunaga R; Taki K; Higashi T; Harada K; Miyata T; Ida S; Imamura Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yamashita Y; Baba H
    J Gastroenterol; 2016 Aug; 51(8):788-95. PubMed ID: 26671045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of esophageal squamous cell carcinoma with submucosal tumor-like tumor due to direct invasion of the gastric wall].
    Nako Y; Shiozaki A; Fujiwara H; Konishi H; Morimura R; Murayama Y; Komatsu S; Ikoma H; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Okamoto K; Sakakura C; Otsuji E
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2097-9. PubMed ID: 24394025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case report of esophageal carcinoma with grade 3 response by preoperative chemotherapy using CDDP/5-FU/LV].
    Bando K; Onda M; Miyashita M; Takahashi Y; Takita M; Matsutani T; Okawa K; Sasajima K; Ujihara Y; Takubo K; Yamashita K
    Gan To Kagaku Ryoho; 1998 May; 25(6):915-8. PubMed ID: 9617331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Factors in Patients Receiving Neoadjuvant 5-Fluorouracil plus Cisplatin for Advanced Esophageal Cancer (JCOG9907).
    Yokota T; Ando N; Igaki H; Shinoda M; Kato K; Mizusawa J; Katayama H; Nakamura K; Fukuda H; Kitagawa Y
    Oncology; 2015; 89(3):143-51. PubMed ID: 25895447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy and side-effects of docetaxel combined with cisplatin on the treatment of local advanced esophageal cancer with concomitant radiation therapy].
    Zhang TR; Zhao T; Xu X; Gu XW; Pan YK
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):791-4. PubMed ID: 21163074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction Chemotherapy Using FAP for Patients with Stage II/III Squamous Cell Carcinoma of the Esophagus.
    Tamura S; Takeno A; Taniguchi H; Katsura Y; Ohmura Y; Kagawa Y; Sakisaka H; Takeda Y; Kato T
    Anticancer Res; 2015 May; 35(5):2975-82. PubMed ID: 25964584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.
    Miyata H; Yoshioka A; Yamasaki M; Nushijima Y; Takiguchi S; Fujiwara Y; Nishida T; Mano M; Mori M; Doki Y
    Cancer; 2009 Jul; 115(14):3324-34. PubMed ID: 19452547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.